'Breakthrough' Alzheimer's drugs unlikely to benefit patients, report suggests
A major review has provoked a backlash after concluding the medicines provide too little benefit to be noticed.
schedule
06:18
visibility
86 visualizações
Fonte: BBC News
A major review has provoked a backlash after concluding the medicines provide too little benefit to be noticed.
